CS
INSP icon

Credit Suisse’s Inspire Medical Systems INSP Stock Holding History

Credit Suisse’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$63.8M Sell
297,084
-58,975
-17% -$11.6M 0.06% 304
2023
Q4 		$72.4M Buy
356,059
+7,759
+2% +$1.26M 0.07% 285
2023
Q3 		$69.1M Buy
348,300
+67,515
+24% +$17M 0.07% 292
2023
Q2 		$91.2M Sell
280,785
-5,571
-2% -$1.59M 0.09% 226
2023
Q1 		$67M Sell
286,356
-36,133
-11% -$9.13M 0.07% 298
2022
Q4 		$81.2M Sell
322,489
-163,555
-34% -$34.9M 0.09% 239
2022
Q3 		$86.2M Buy
486,044
+70,941
+17% +$14.3M 0.1% 218
2022
Q2 		$75.8M Sell
415,103
-1,838
-0.4% -$367K 0.08% 263
2022
Q1 		$107M Sell
416,941
-266,070
-39% -$60.8M 0.09% 234
2021
Q4 		$157M Sell
683,011
-10,743
-2% -$2.62M 0.08% 234
2021
Q3 		$162M Sell
693,754
-97,791
-12% -$20.4M 0.09% 221
2021
Q2 		$155M Buy
791,545
+103,584
+15% +$20.5M 0.08% 252
2021
Q1 		$142M Buy
687,961
+62,388
+10% +$13.3M 0.07% 291
2020
Q4 		$118M Buy
625,573
+205,692
+49% +$33.6M 0.06% 355
2020
Q3 		$54.2M Buy
419,881
+402,385
+2,300% +$44.3M 0.03% 574
2020
Q2 		$1.52M Buy
17,496
+11,649
+199% +$895K ﹤0.01% 2599
2020
Q1 		$352K Sell
5,847
-6,146
-51% -$455K ﹤0.01% 3314
2019
Q4 		$890K Sell
11,993
-7,110
-37% -$457K ﹤0.01% 3218
2019
Q3 		$1.17M Buy
19,103
+12,874
+207% +$848K ﹤0.01% 2908
2019
Q2 		$378K Sell
6,229
-66,450
-91% -$3.58M ﹤0.01% 3560
2019
Q1 		$4.13M Buy
+72,679
New +$3.93M ﹤0.01% 1869
2018
Q4 		– Sell
-24,027
Closed -$1.01M – 3932
2018
Q3 		$1.01M Buy
+24,027
New +$1.13M ﹤0.01% 2866

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Credit Suisse's INSP Position: Q1 2024 in Review

Credit Suisse reduced its Inspire Medical Systems (INSP) stake by 17% in Q1 2024, selling an estimated $11.6M and leaving 297,084 shares worth $63.8M. The position accounts for 0.06% of the portfolio, ranked #304.

Credit Suisse first reported a position in INSP in Q3 2018 and has held it in 22 quarters since. The position peaked at $162M in Q3 2021. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

  • Credit Suisse held 297,084 shares of Inspire Medical Systems worth $63.8M as of Q1 2024.
  • Credit Suisse sold 58,975 Inspire Medical Systems shares in Q1 2024, an estimated $11.6M.
  • Inspire Medical Systems made up 0.06% of Credit Suisse's portfolio in Q1 2024, its #304 holding.
  • Credit Suisse first reported a position in Inspire Medical Systems in Q3 2018 and has held it in 22 quarters since.
  • Credit Suisse's Inspire Medical Systems position peaked at $162M in Q3 2021.
  • 328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.